Core Scientific just locked in the second half of its billion-dollar war chest. The Austin-based data center operator announced March 23 that JPMorgan Chase committed an additional $500 million to its credit facility, matching Morgan Stanley’s initial tranche from earlier this month and bringing total funded commitments to $1 billion.

The speed here matters. Core Scientific secured the first $500 million from Morgan Stanley on March 5, 2026. Less than three weeks later, they’ve doubled it. Both tranches carry identical terms—SOFR plus 250 basis points, working out to roughly 7.8% at current rates—under a 364-day facility with an accordion feature that made this expansion possible.

CORZ shares traded at $15.50 on the announcement date, giving the company a market cap around $5 billion. That means this credit line represents roughly 20% of their entire market value in available firepower.

What They’re Building

CEO Adam Sullivan isn’t being coy about the strategy. The company plans to deploy this capital toward data center infrastructure—equipment purchases, land acquisition, pre-development costs, and critically, securing additional power capacity.

Core Scientific operates ten facilities across seven states, with the heaviest concentration in Texas (three sites). The company still runs Bitcoin mining operations but has been aggressively converting existing infrastructure to support AI workloads and high-density colocation services.

This isn’t a pivot born of desperation. It’s a calculated bet that their existing power agreements and physical infrastructure—originally built for the energy-intensive demands of crypto mining—translate directly to the similarly power-hungry world of AI computing.

Wall Street’s AI Infrastructure Play

Having both Morgan Stanley and JPMorgan on the same deal sheet sends a signal. These aren’t crypto-native lenders making speculative bets. This is traditional Wall Street capital flowing into what they clearly view as AI infrastructure, not a Bitcoin mining operation.

The 364-day term suggests this functions as bridge financing—likely positioning Core Scientific for a larger, longer-term capital raise once they demonstrate execution on the AI conversion strategy.

For traders watching the AI infrastructure buildout, the financing terms matter. Sub-8% rates for a company that emerged from bankruptcy in January 2024 indicates institutional confidence in the underlying assets, regardless of what workloads run on them.

Image source: Shutterstock